Eli Avisar

3.2k total citations
72 papers, 2.2k citations indexed

About

Eli Avisar is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Eli Avisar has authored 72 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 35 papers in Cancer Research and 25 papers in Surgery. Recurrent topics in Eli Avisar's work include Breast Cancer Treatment Studies (33 papers), Breast Implant and Reconstruction (17 papers) and Breast Lesions and Carcinomas (16 papers). Eli Avisar is often cited by papers focused on Breast Cancer Treatment Studies (33 papers), Breast Implant and Reconstruction (17 papers) and Breast Lesions and Carcinomas (16 papers). Eli Avisar collaborates with scholars based in United States, Israel and Sweden. Eli Avisar's co-authors include Salomone Di Saverio, Juan C. Gutierrez, D. Castaing, F Kunstlinger, S. Giachetti, Françis Lévi, René Adam, Daniel Azoulay, Arié Ariche and Stefan Glück and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eli Avisar

65 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Avisar United States 19 1.4k 567 454 431 385 72 2.2k
Monika Klinkhammer‐Schalke Germany 27 1.4k 1.0× 607 1.1× 372 0.8× 616 1.4× 179 0.5× 171 2.9k
Lily Lai United States 25 924 0.7× 453 0.8× 271 0.6× 530 1.2× 139 0.4× 75 1.9k
Cinzia Orlandini Italy 29 2.2k 1.6× 630 1.1× 217 0.5× 748 1.7× 478 1.2× 74 3.7k
Peter J. Rosen United States 29 1.1k 0.8× 585 1.0× 616 1.4× 193 0.4× 131 0.3× 100 2.9k
Cristine Allmer United States 23 1.4k 1.0× 259 0.5× 1.1k 2.4× 693 1.6× 275 0.7× 84 2.9k
Dieter Koeberle Switzerland 23 1.6k 1.2× 430 0.8× 218 0.5× 562 1.3× 306 0.8× 87 2.3k
Camilla Qvortrup Denmark 23 1.1k 0.8× 249 0.4× 253 0.6× 260 0.6× 156 0.4× 86 1.6k
Howard M. Gross United States 27 1.4k 1.0× 530 0.9× 446 1.0× 272 0.6× 54 0.1× 55 2.6k
Anne M. Noonan United States 27 1.3k 0.9× 360 0.6× 189 0.4× 287 0.7× 185 0.5× 117 2.1k
Eui Kyu Chie South Korea 31 2.4k 1.7× 989 1.7× 437 1.0× 1.4k 3.3× 226 0.6× 233 3.9k

Countries citing papers authored by Eli Avisar

Since Specialization
Citations

This map shows the geographic impact of Eli Avisar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Avisar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Avisar more than expected).

Fields of papers citing papers by Eli Avisar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Avisar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Avisar. The network helps show where Eli Avisar may publish in the future.

Co-authorship network of co-authors of Eli Avisar

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Avisar. A scholar is included among the top collaborators of Eli Avisar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Avisar. Eli Avisar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riaz, Nazia, Anne Huibers, Stanley P. L. Leong, et al.. (2025). Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma. Annals of Surgical Oncology. 32(5). 3189–3197. 1 indexed citations
2.
Narvaez‐Rojas, Alexis Rafael, Shaina Sedighim, Clara Milikowski, et al.. (2024). Is primary breast melanoma a true pathological entity? The argument against it. Heliyon. 10(18). e37224–e37224.
5.
Silva, Iago De Castro, Dido Franceschi, Susan B. Kesmodel, et al.. (2022). Persistent and interdependent: Racial disparities and their mechanisms in postmastectomy breast reconstruction. Surgery. 172(1). 25–30. 5 indexed citations
6.
Koru‐Sengul, Tulay, et al.. (2021). Does the Type of Surgery After Preoperative Systemic Therapy for T3/T4 Breast Cancer Impact Survival?. 5(6). 26–36. 1 indexed citations
7.
Tjendra, Youley, et al.. (2021). Axillary Reverse Lymphatic Mapping in the Treatment of Axillary Accessory Breast Cancer: A Case Report and Review of Management. SHILAP Revista de lepidopterología. 18(1). 1–5. 1 indexed citations
8.
Goel, Neha, Sina Yadegarynia, Kristin N. Kelly, et al.. (2021). Axillary response rates to neoadjuvant chemotherapy in breast cancer patients with advanced nodal disease. Journal of Surgical Oncology. 124(1). 25–32. 5 indexed citations
9.
Kelly, Kristin N., Alexandra Hernández, Sina Yadegarynia, et al.. (2021). Overcoming disparities: Multidisciplinary breast cancer care at a public safety net hospital. Breast Cancer Research and Treatment. 187(1). 197–206. 14 indexed citations
10.
Collier, Amber L., Kristin N. Kelly, Neha Goel, et al.. (2020). Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 27(6). 1830–1841. 12 indexed citations
11.
Chang, James M., Heidi Kosiorek, Amylou C. Dueck, et al.. (2017). Stratifying SLN incidence in intermediate thickness melanoma patients. The American Journal of Surgery. 215(4). 699–706. 21 indexed citations
12.
Schuitevoerder, Darryl, Stanley P. L. Leong, Jonathan S. Zager, et al.. (2017). Is pelvic sentinel node biopsy necessary for lower extremity and trunk melanomas?. The American Journal of Surgery. 213(5). 921–925. 4 indexed citations
13.
Özmen, Tolga, et al.. (2017). Management of the Positive Axilla in 2017. Cureus. 9(5). e1216–e1216. 4 indexed citations
14.
Spector, Neil L., Faith C. Robertson, Sarah Bacus, et al.. (2015). Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor. PLoS ONE. 10(11). e0142845–e0142845. 21 indexed citations
15.
Gudenkauf, Lisa M., Michael H. Antoni, Jamie M. Stagl, et al.. (2015). Brief cognitive–behavioral and relaxation training interventions for breast cancer: A randomized controlled trial.. Journal of Consulting and Clinical Psychology. 83(4). 677–688. 80 indexed citations
16.
Han, Dale, Jonathan S. Zager, Yu Shyr, et al.. (2013). Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma. Journal of Clinical Oncology. 31(35). 4387–4393. 161 indexed citations
17.
Markert, Matthew, et al.. (2011). Predictive value of BI-RADS classification for breast imaging in women under age 50. Breast Cancer Research and Treatment. 130(3). 819–823. 4 indexed citations
18.
Sarosiek, Kristopher A., Raquel Malumbres, Hovav Nechushtan, et al.. (2009). Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood. 115(3). 570–580. 66 indexed citations
19.
Molina, Manuel, Dido Franceschi, Mercè Jordà, et al.. (2008). Breast Specimen Orientation. Annals of Surgical Oncology. 16(2). 285–288. 35 indexed citations
20.
Hodgson, Nicole C., et al.. (2007). Angiosarcomas of the Breast. American Journal of Clinical Oncology. 30(6). 570–573. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026